Related Experiment Video
Updated: Jan 13, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Functional inactivation of oligosaccharyltransferase a isoform suppresses tumor metastasis
Yang Shi1,2, Yu Mizote3, Akinobu Honda4
1Department of Glyco-Oncology and Medical Biochemistry, Research Center, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 541-8567, Japan.
Abstract:
Oligosaccharyltransferase (OST), which is a multi-membrane protein complex that catalyzes asparagine-linked glycosylation (N-glycosylation) in the endoplasmic reticulum (ER), is a potential target to eradicate refractory cancer. Mammals express two distinct OST isoforms (OST-A and OST-B) that exhibit different acceptor site specificity to maximize N-glycosylation efficiency; however, the role of individual OST isoforms in tumor progression is not fully understood. Here, using mouse melanoma model, we showed that gene-edited knockout of either one of the OST isoforms did not compromise subcutaneous tumor growth, while their co-expression was required for efficient experimental lung metastasis. We further showed that the cytosolic N-terminal region of Stt3a, which is the catalytic subunit of OST-A, was critical for the N-glycosylation reaction and lung metastasis. This study opens a novel avenue for selective manipulation of OST-A activity, which might offer potential therapeutic strategies for metastatic cancers.
Insights
Oligosaccharyltransferase (OST) isoforms are crucial for cancer metastasis, not primary tumor growth. Targeting OST-A offers a potential strategy for treating metastatic cancers.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Oligosaccharyltransferase (OST) is a key enzyme complex in the endoplasmic reticulum (ER) responsible for N-linked glycosylation.
- Mammals have two OST isoforms, OST-A and OST-B, with distinct specificities, but their roles in cancer progression are unclear.
Purpose of the Study:
- To investigate the role of individual OST isoforms (OST-A and OST-B) in tumor progression and metastasis.
- To identify potential therapeutic targets for refractory and metastatic cancers.
Main Methods:
- Utilized a gene-edited mouse melanoma model to study OST isoform function.
- Analyzed the impact of OST isoform knockout on subcutaneous tumor growth and experimental lung metastasis.
- Investigated the role of the Stt3a subunit's N-terminal region in N-glycosylation and metastasis.
Main Results:
- Knockout of individual OST isoforms did not affect subcutaneous tumor growth.
- Co-expression of OST-A and OST-B was essential for efficient experimental lung metastasis.
- The cytosolic N-terminal region of Stt3a (OST-A catalytic subunit) was critical for N-glycosylation and lung metastasis.
Conclusions:
- Individual OST isoforms are dispensable for primary tumor growth but critical for metastasis.
- Selective manipulation of OST-A activity presents a novel therapeutic strategy for metastatic cancers.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
MicroRNAs
MicroRNAs
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

